About Us | Contact

Dr. David Jacob Andorsky Investigator

Hematology & Oncology Boulder Community Health NPI1609061837
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$628,648.74
from 49 payments in the last 6 years

Total Cash or Cash Equivalent

$603,391.98
from 30 payments in the last 6 years

Total In-kind Items & Services

$25,256.76
from 19 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
06/01/2021 General (Non-Research) In-kind items and services Education $11.92 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 845870427
07/02/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1611.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 829610385
02/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $550.00 Details
Payment from AbbVie Inc.
Payment Record ID 793892507
01/29/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2275.00 Details
Payment from Celgene Corporation
Payment Record ID 783668987
02/26/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1800.00 Details
Payment from Celgene Corporation
Payment Record ID 783668977
09/30/2020 Research In-kind items and services Biological $6192.89 Details
Payment from F. Hoffmann-La Roche AG
Paymment Research Study Antibody-drug conjugates for previously treated aggressive lymphomas focus on polatuzumab vedotin
Payment Record ID 742977557
01/15/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1074.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 736284281
08/17/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1611.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 736061661
12/30/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1342.50 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 735797819
09/11/2019 General (Non-Research) Cash or cash equivalent Honoraria $150.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 730071711
08/13/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1012.50 Details
Payment from Celgene Corporation
Payment Record ID 727782945
01/09/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1100.00 Details
Payment from AbbVie Inc.
Payment Record ID 721677903
02/22/2019 Research Cash or cash equivalent $14809.95 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20
Payment Record ID 686159089
03/22/2019 Research Cash or cash equivalent $20498.84 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20
Payment Record ID 686159087
02/13/2019 Research Cash or cash equivalent $10043.02 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20
Payment Record ID 686159001
01/04/2019 Research Cash or cash equivalent $16385.20 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20
Payment Record ID 686158999
02/22/2019 Research Cash or cash equivalent $1250.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20
Payment Record ID 686158997
01/25/2019 Research Cash or cash equivalent Drug $7644.00 Details
Payment from Acerta Pharma LLC
Paymment Research Study A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP-196 in Combination with Obinutuzumab, and ACP-196 Monotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia
Payment Record ID 685006143
01/11/2019 Research Cash or cash equivalent Drug $3420.87 Details
Payment from AstraZeneca Pharmaceuticals LP
Paymment Research Study Treatment Patterns Outcomes and Patient Reported Quality of Life A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents
Payment Record ID 685005991
02/12/2019 Research In-kind items and services Drug $3031.00 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 675413865
05/08/2019 Research In-kind items and services Drug $476.00 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-007
Payment Record ID 675413863
02/01/2019 Research Cash or cash equivalent Drug $2428.00 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 675413861
06/05/2018 General (Non-Research) In-kind items and services Food and Beverage $20.76 Details
Payment from Genentech USA, Inc.
Payment Record ID 602313783
11/21/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $3000.00 Details
Payment from Celgene Corporation
Payment Record ID 595597346
06/03/2018 General (Non-Research) In-kind items and services Food and Beverage $42.93 Details
Payment from Celgene Corporation
Payment Record ID 595531065
03/09/2018 General (Non-Research) In-kind items and services Education $10.51 Details
Payment from Celgene Corporation
Payment Record ID 595122359
08/01/2018 Research In-kind items and services Drug $1524.00 Details
Payment from Celgene Corporation
Paymment Research Study CC-122-DLBCL-001
Payment Record ID 595022710
02/19/2018 Research In-kind items and services Drug $6934.00 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 595022701
01/05/2018 Research Cash or cash equivalent Drug $162883.15 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 595022691
12/12/2018 Research Cash or cash equivalent $1728.72 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20
Payment Record ID 586486141
12/12/2018 Research Cash or cash equivalent $17677.03 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20
Payment Record ID 586486127
07/06/2018 Research Cash or cash equivalent Drug $8592.20 Details
Payment from AstraZeneca Pharmaceuticals LP
Paymment Research Study Treatment Patterns Outcomes and Patient Reported Quality of Life A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents
Payment Record ID 556975099
10/24/2018 Research Cash or cash equivalent Drug $9996.00 Details
Payment from Acerta Pharma LLC
Paymment Research Study A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP-196 in Combination with Obinutuzumab, and ACP-196 Monotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia
Payment Record ID 556974757
10/30/2018 General (Non-Research) In-kind items and services Food and Beverage $13.08 Details
Payment from Janssen Scientific Affairs, LLC
Payment Record ID 549290709
07/06/2017 General (Non-Research) In-kind items and services Education $7.70 Details
Payment from AbbVie, Inc.
Payment Record ID 514011675
03/01/2017 Research In-kind items and services Drug $3368.00 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 493255991
02/01/2017 Research Cash or cash equivalent Drug $216033.70 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 493255989
02/06/2017 Research In-kind items and services Drug $1463.00 Details
Payment from Celgene Corporation
Paymment Research Study AG-221-AML-004
Payment Record ID 493255983
06/03/2017 General (Non-Research) In-kind items and services Food and Beverage $70.63 Details
Payment from Celgene Corporation
Payment Record ID 490180805
06/03/2017 General (Non-Research) In-kind items and services Food and Beverage $27.30 Details
Payment from Genentech USA, Inc.
Payment Record ID 488302889
05/23/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $400.00 Details
Payment from Genentech USA, Inc.
Payment Record ID 488302851
10/27/2016 General (Non-Research) In-kind items and services Food and Beverage $15.39 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 406052702
10/11/2016 General (Non-Research) In-kind items and services Education $18.75 Details
Payment from Pfizer Inc.
Payment Record ID 404306794
08/03/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3150.00 Details
Payment from Celgene Corporation
Payment Record ID 401557472
07/20/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $225.00 Details
Payment from Celgene Corporation
Payment Record ID 401531476
07/20/2016 General (Non-Research) In-kind items and services Food and Beverage $130.90 Details
Payment from Celgene Corporation
Payment Record ID 401528716
02/02/2016 Research In-kind items and services Drug $1898.00 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 401471504
02/24/2016 Research Cash or cash equivalent Drug $90575.30 Details
Payment from Celgene Corporation
Paymment Research Study CC-5013-NHL-008
Payment Record ID 401471474
11/01/2016 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125.00 Details
Payment from SANOFI-AVENTIS U.S. LLC
Payment Record ID 394529010
;